Krsnaa Diagnostics to acquire 24% stake in start-up Apulki Healthcare

Krsnaa Diagnostics plans to acquire a 24% stake in Apulki Healthcare, securing exclusive rights to provide diagnostic services at Apulki’s oncology and cardiology hospitals. This partnership will ensure Krsnaa’s leadership in these segments for over 30 years, offering advanced diagnostic technologies across Apulki’s planned network of hospitals in India.